High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy

Author(s):

Simon J. Hume, Danny K. Wong, Man Fung Yuen, Kathy Jackson, Sara Bonanzinga, Sara Vogrin, Samuel A.L. Hall, Gareth S. Burns, Paul V. Desmond, Vijaya Sundararajan, Dilip Ratnam, Miriam T. Levy, John S. Lubel, Amanda J. Nicoll, Simone I. Strasser, William Sievert, Meng C. Ngu, Marie Sinclair, Christopher Meredith, Gail Matthews, Peter A. Revill, Margaret Littlejohn, Scott Bowden, Kumar Visvanathan, Jacinta A. Holmes, Alexander J. Thompson

Details:

Liver International, Volume 44, Issue 10, 2024-10-01

Article Link: Click here

Affiliations:

• The Peter Doherty Institute for Infection and Immunity
• Western Health
• Concord Repatriation General Hospital
• University of Melbourne
• St. Vincent's Hospital Sydney
• Royal Prince Alfred Hospital
• Monash Health
• Eastern Health
• The University of Hong Kong
• Austin Health
• St. Vincent's Hospital Melbourne
• Bankstown-Lindcombe Hospital
• Alfred Health
• Liverpool Hospital